Gibson Christopher's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Oct 10, 2025
- Accession no.
- 0001856369-25-000007
- Filed
- Oct 10, 2025
- Trade date
- Oct 10, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $604.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gibson ChristopherCIK 0001856369 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | Class A Common Stock | CConversionAcquired | +120,000 | $0.00 | $0 | 1,074,229 | Direct | |
| Oct 10, 2025 | Class A Common Stock | SSaleDisposed | −100,000 | $6.04 | −$604,000 | 974,229 | Direct | |
| Oct 10, 2025 | Class A Common Stock | GGiftDisposed | −20,000 | $0.00 | $0 | 954,229 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | Class A Common Stock | CConversionDisposed | −120,000 | $0.00 | $0 | 5,133,034 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.